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Despite increasing interest in the possible relationships between bacteria and the different stages of cancer
development, the association of bacteria with cancer of the oral cavity has yet to be adequately examined. With
that in mind, the primary objective of this study was to identify any bacterial species within oral squamous cell
carcinoma tissue using a standard microbiological culture approach. At the time of surgery, a 1-cm3 portion
of tissue was harvested from deep within the tumor mass using a fresh blade for each cut. Whenever possible,
“superficial” portions from the mucosa overlying the tumor and nontumorous control specimens from at least
5 cm away from the primary tumor site were also obtained. Surface contamination was eliminated by immer-
sion in Betadine and washing with phosphate-buffered saline. Each specimen was aseptically macerated and
cultured on nonselective media under both aerobic and anaerobic conditions. Isolates were identified by 16S
rRNA gene sequencing. Twenty deep-tissue specimens, 19 with corresponding superficial tissues and 12 with
control tissues, were successfully processed. A diversity of bacterial taxa were isolated and identified, including
several putatively novel species. Most isolates were found to be saccharolytic and acid-tolerant species.
Notably, some species were isolated only from either the tumorous or nontumorous tissue type, indicating a
degree of restriction. Successful surface decontamination of the specimens indicates that the bacteria detected
were from within the tissue. A diversity of bacterial groups have been isolated from within oral squamous cell
carcinoma tissue. The significance of these bacteria within the tumor warrants further study.
Oral cancer is the sixth most common malignancy worldwide
(32) and is particularly prevalent in developing countries, such
as in Southeast Asia, where up to 40 percent of all malignan-
cies are located within the oral cavity (25). More than 90% of
cancers in the mouth are squamous cell carcinomas (SCCs)
originating from the oral mucosa (5). With an average all-
stage, 5-year survival rate for oral cancer of less than 50%, the
annual mortality figures are comparable to those of carcinoma
of the cervix and malignant melanoma (3, 40). There is evi-
dence that the incidence of cancer of the oral cavity is increas-
ing in many parts of the world, including the United Kingdom
(8, 15, 16). In the past, oral cancer predominantly affected men
in their sixth or seventh decade. However, more recently the
male-to-female ratio has reduced dramatically and there has
been a striking increase in the number of cases in those under
the age of 45 (15, 38).
It has been reported that the majority of cases of head and
neck cancer can be related to tobacco use and heavy alcohol
consumption (10). Other possible risk factors include viral
infections (29), poor oral hygiene (14), and infection with Can-
dida species. The latter microorganisms are associated with
some forms of leukoplakic lesions, the presence of which has
long been recognized as an independent risk factor for carci-
noma (4).
The involvement of other microorganisms, particularly bac-
teria, has not been studied to any great extent, although re-
cently there has been increasing evidence to suggest that closer
study of this issue may be warranted. A number of bacterial
species have been associated with different cancers following
either epidemiological or laboratory-based studies. For exam-
ple, Chlamydia trachomatis infection has been associated with
an increased risk for the development of invasive cervical car-
cinoma (37). Bacteremia and endocarditis due to Streptococcus
bovis have likewise been linked with malignancies in the colon
(7), and Helicobacter pylori infection has long since been con-
sidered a causative agent of both gastric adenocarcinoma and
mucosa-associated lymphoid tissue lymphomas (1, 35). More-
over, several mechanisms by which different bacteria may play
a role in cancer development have been proposed, for instance,
through the induction of chronic inflammation, by interfer-
ence, either directly or indirectly, with eukaryotic cell cycle and
signaling pathways (13), or via the metabolism of potentially
carcinogenic substances. The latter mechanism is of relevance
in the oral cavity, where the local microflora may promote
carcinogenesis by converting ethanol into its carcinogenic de-
rivative, acetaldehyde. Following the ingestion of alcohol, sal-
ivary bacteria have been shown to produce levels of acetalde-
hyde that can induce DNA damage, mutagenesis, and secondary
hyperproliferation of the epithelium (23, 27). Interestingly, mi-
crobial acetaldehyde production is increased in heavy drinkers
and smokers, offering a possible explanation for these risk
factors (9).
The association of bacteria with oral tumors is of increasing
interest. In a study of intraoral carcinomas, Nagy et al. (20)
demonstrated a difference in the microflora associated with the
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surface of tumors in comparison to control sites. More recently
it has also been reported that patients with oral SCC (OSCC)
tend to possess significantly raised concentrations of certain
bacteria in their saliva. This apparent alteration of the oral
microflora in OSCC cases is of particular interest because of its
potential application as a diagnostic tool to predict oral cancer
(17). In order to demonstrate a role for bacteria in the devel-
opment of oral cancer, the first step must be to identify such
organisms within tumor specimens. Furthermore, sufficient at-
tention must be given to the elimination from any tissues tested
of the microbes that occur naturally on the surfaces of the
tumors. In addition, salivary contamination of the sample must
be prevented during subsequent handling. The presence of
Streptococcus anginosus DNA in oropharyngeal tumors has
been reported following studies using specific PCR primers
(18, 31). However, this molecular approach was limited to a
single group of bacteria, and no inferences can be made re-
garding the viability and therefore potential activity of the
species detected.
The aim of this investigation was to determine whether vi-
able bacteria are present within the tissue of oral squamous
cell carcinoma. A prerequisite of this was the development of
a robust method for the elimination of surface microbial con-
tamination from specimens of tumor tissue.
MATERIALS AND METHODS
Sample collection. Tissue specimens were obtained from 16 male and 4 female
OSCC patients with an average age of 66.9 years ( 12.7). Ethical approval for
the study was granted by the South Wales Local Ethics Research Committee, and
subjects agreed to participate with their informed consent. Tumors were re-
moved surgically, and specimens from the resected OSCC were harvested under
aseptic conditions. The technique involved the surgeon rescrubbing and placing
the specimen on a separate sterile surface. With a new blade for each cut, a 1-cm3
specimen was removed without compromising the pathological margins. This
specimen was further divided into a “deep tissue” specimen (consisting entirely
of tissue from within the tumor mass) and a “superficial” specimen (consisting of
tissue from within and from the surface of the tumor). Whenever possible, a
control specimen consisting of nontumorous tissue harvested at least 5 cm away
from the primary tumor site was also obtained.
Specimens were aseptically transferred to the laboratory in separate vials of
transport medium, used to maintain the viability of any bacterial cells present.
Transport medium was comprised of tryptone (1% wt/vol; Oxoid), yeast extract
(0.5% wt/vol; Oxoid), glucose (0.1% wt/vol; BDH Ltd.), cysteine hydrochloride
(0.1% wt/vol; BDH Ltd.), sodium hydroxide (50 mM; Sigma), and horse serum
(2% vol/vol; TCS Ltd.) and was sterilized by filtration using a 0.2-m filter.
All subsequent handling of the specimens was carried out using aseptic tech-
nique on surfaces cleaned with Hycolin phenolic disinfectant (2% vol/vol; Bilau-
rand Labs Ltd.). Tissue specimens were placed in Betadine antiseptic solution
(Seton Healthcare Group plc) for 3 min to disinfect the surface of each. Subse-
quently, tissues were vortexed in multiple 500-l aliquots of phosphate-buffered
saline (PBS) to encourage the removal of any bacteria on the tissue surface. Final
washes were retained and analyzed by both culture-dependent and culture-
independent techniques to determine whether surface decontamination was suc-
cessful.
Specimens were aseptically bisected. Half of each was placed in Tris-EDTA
buffer (pH 7.4) and stored at 80°C for molecular analysis. The remainder was
subjected to immediate culture-dependent analysis.
Bacterial culture. Tissue specimens were aseptically macerated with dispos-
able scalpels and vortexed for 30 seconds in PBS (500 l), and the neat suspen-
sions were used to make 10-fold (101) and 100-fold (102) dilutions. Neat
suspensions (50 l) were each spread onto blood agar (BA), fastidious anaerobe
agar (FAA) (BA and FAA supplemented with 5% defibrinated sheep blood;
TCS Biosciences Ltd.), and Sabouraud’s agar (Lab MTM; International Diag-
nostics Group plc). The dilutions and final PBS washes of the specimens (see
above) were spread onto BA and FAA. BA and Sabouraud’s agar plates were
incubated aerobically at 37°C for 48 h. FAA plates were incubated in an anaer-
obic cabinet at 36°C for 96 h.
Following incubation, all colony types on the plates were subcultured for
purity, the cellular morphologies of Gram-stained smears were recorded, and
isolates were stored at 80°C using Microbank cryovials (Pro-Lab Diagnostics)
prior to identification by 16S rRNA gene sequence analysis.
Molecular identification of isolates. Genomic DNA was extracted from sus-
pensions of each of the bacterial isolates using a commercial kit (Puregene;
Gentra Systems) according to the manufacturer’s instructions (extraction proto-
col for 1 ml gram-positive bacteria; http://www.gentra.com/pdf/01120.pdf).
PCR amplification of 16S rRNA genes was performed in a reaction volume of
50 l, consisting of 0.2 mM each deoxynucleoside triphosphate, 2.0 mM MgCl2,
1.5 U Taq DNA polymerase, 5 l 10 PCR buffer (all reagents from Promega),
5 l (between 50 fg and 50 ng) of extracted DNA as template, and 0.5 M each
primer. The primer pair used were 27F (5-GTGCTGCAGAGAGTTTGATCC
TGGCTCAG-3) and 1492R (5-CACGGATCCTACGGGTACCTTGTTACG
ACTT-3), specific for the domain Bacteria (6) (synthesized by Invitrogen). A
touchdown protocol was used whereby in the first cycle, denaturation was per-
formed at 94°C for 6 min, primer annealing was performed at 65°C for 1 min, and
extension was performed at 72°C for 2 min. In subsequent cycles, denaturation
was performed for 1 min and the annealing temperature was decreased by 2°C
each cycle for 11 cycles, after which 25 cycles were carried out under the same
conditions. In the final cycle, extension was performed for 12 min. Contamina-
tion controls (tissue surface washes) were also subjected to PCR amplification;
negative results indicated successful decontamination.
The 16S rRNA gene PCR products were partially sequenced using the 357F
primer (5-CTCCTACGGGAGGCAGCAG-3) (12), ABI Prism BigDye Termi-
nator cycle sequencing ready reaction kits (Perkin-Elmer), and an automated
DNA sequencer (ABI PRISM 3100 Genetic Analyzer; Applied Biosystems). This
gave reliable sequences of at least 500 nucleotides in length, which were com-
pared to all GenBank DNA sequence entries using the FASTA sequence ho-
mology search program (http://www.ebi.ac.uk/services/index.html) (22).
Whenever this sequence was insufficient to provide a conclusive identification,
PCR products were further sequenced using the 27F and 1492R primers to give
a sequence of at least 1,200 nucleotides in length.
Nucleotide sequence accession numbers. Sequences AY880043 through AY880059
were deposited into GenBank.
RESULTS
The results of the PCR and both aerobic and prolonged
anaerobic cultures of surface washings were routinely negative,
indicating that the surface decontamination protocol used was
successful. Bacteria were isolated from all specimens: 20 deep-
tissue tumor specimens, 19 corresponding superficial speci-
mens, and the nontumorous control tissues that were obtained
from 12 of the 20 patients.
The species identities are summarized in Table 1. An aver-
age of 6 isolates was cultured from each specimen with a total
of 90 distinct species or phylotypes. The isolates were mostly
bacterial, but also included isolates of Candida albicans from
three patients and a single isolate of a Saccharomyces species.
A wide range of bacteria was seen, including a number of taxa
with low 16S rRNA gene sequence homology to anything pre-
viously existing in the public databanks. Complete 16S rRNA
gene sequences were obtained for these seemingly novel taxa
and deposited with GenBank; nucleotide accession numbers
are given in Table 1.
For all patients studied, the superficial tissues yielded the
same isolates found in the corresponding deep-tissue speci-
mens, with additional species in most cases. Comparison of the
proportions of each sample type positive for each species re-
vealed 17 organisms for which the difference in proportion
between tumorous and nontumorous tissues was at least 10%,
where “tumorous” tissues represented both the deep tumor
and superficial samples combined (Table 2).
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TABLE 1. A summary of the microorganisms cultured from tissue specimens, grouped according to phyluma
Species
No. of tissue specimens cultured, by source
Deep tumor
(n  20)
Tumor and overlying mucosa
(“superficial”) (n  19)
Nontumorous control
(n  12)
Proteobacteria
Acinetobacter lwoffi 1 1
Citrobacter koseri 1 1
Eikenella corrodens 1 1
Moraxella osloensis 2
Neisseria elongata 1
Neisseria perflava/subflava 1 1
Pseudomonas aeruginosa 1 1
Pseudomonas monteilii 1
Serratia marcescens 1 1 1
Unknown Moraxella-like sp.b 1
Actinobacteria
Actinomyces graevenitzii 1
Actinomyces odontolyticus 1 2
Actinomyces viscosus 1
Atopobium parvulum 1 2 3
Atopobium rimae 1
Bifidobacterium longum 1
Bifidobacterium sp. (oral strain H6-M4 phylotype)c 2
Brachybacterium rhamnosum 1
Corynebacterium singulare 1
Corynebacterium striatum 1
Corynebacterium tuberculostearicum 2 3 1
Dermabacter hominis 1 1
Dietzia psychralcaliphila 1
Gordonia sputi 1
Micrococcus luteus 5 6
Micrococcus lylae 1 1
Olsenella uli 1
Propionibacterium acnes 6 7 6
Propionibacterium avidum 1 1
Propionibacterium granulosum 1
Rothia amarae 1
Rothia mucilaginosa 1 1 2
Scardovia genosp. C1d 1 1
Streptomyces aureus/griseorubiginosus 1
Unknown Corynebacterium-like sp. phylotype ie 1
Unknown Corynebacterium-like sp. phylotype iif 1 1
Unknown Georgenia-like sp.g 1 1
Unknown Olsenella-like sp.h 1 1
Firmicutes
Bacillus licheniformis 1 1
Bacillus mycoides/weihenstephanensis 1 1
Bacillus psychrodurans 1 1
Dialister invisus 1
Dialister pneumosintes 1 1
Enterococcus faecalis 1
Eubacterium yurii 1
Exiguobacterium oxidotolerans 2 2
Finegoldia magna 1 2 1
Gemella haemolysans 2
Gemella morbillorum 1 1 1
Granulicatella adiacens 3 5 3
Lactobacillus casei/zeae 1 1
Lactobacillus crispatus 1 1
Lactobacillus fermentum 2 2 1
Lactobacillus gasseri 3 3 1
Lactobacillus rhamnosus 1 1 1
Lactobacillus salivarius 1
Megasphaera micronuciformis 1 1
Mogibacterium neglectum 1 1
Peptostreptococcus micros 4 4 2
Selenomonas dianae 1
Continued on following page
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DISCUSSION
To our knowledge this is the first time that viable bacteria
have been detected within the tissue of oral squamous cell
carcinoma. Immersion in Betadine was required to elimi-
nate any viable bacteria on the surface that may have been
present due to salivary or instrument contamination during
surgery.
A diversity of species were isolated. However, it is important
to remember that this is not a comprehensive analysis of the
microflora; it has been well established that approximately
50% of oral bacteria are not cultivable by standard culture
techniques as used in this study (36). Nevertheless, cultivation
of bacteria remains a useful diagnostic tool for the detection
and identification of viable organisms, including many known
pathogenic species.
The majority of the taxa detected have previously been iso-
lated from the oral cavity. However, there were a small number
of exceptions. For example, some species previously only re-
ported as isolates from environmental sources were detected,
including Dietzia psychralcaliphila and Gordonia sputi.
TABLE 1—Continued
Species
No. of tissue specimens cultured, by source
Deep tumor
(n  20)
Tumor and overlying mucosa
(“superficial”) (n  19)
Nontumorous control
(n  12)
Selenomonas sputigena 1
Solobacterium moorei 1
Staphylococcus aureus 2 2
Staphylococcus capitis/caprae/epidermidis 2 5 2
Staphylococcus cohnii 1 1
Staphylococcus hominis 1 1
Staphylococcus saprophyticus 1 1
Staphylococcus warneri 2 3 1
Streptococcus agalactiae 1 1
Streptococcus anginosus 1 4 1
Streptococcus constellatus 2 4 2
Streptococcus cristatus 1 1
Streptococcus gordonii 1 1
Streptococcus mitis/oralis 2 5 5
Streptococcus parasanguinis 3 6 5
Streptococcus salivarius 2 3 3
Streptococcus sp. (oral strain T4-E3 phylotype)i 1
Unknown gram-positive anaerobic coccoid species j 1
Veillonella atypica 1 1
Veillonella dispar 1 1 3
Veillonella parvula 2 2
Bacteroidetes
Prevotella intermedia 1
Prevotella melaninogenica 2 3
Prevotella veroralis 2
Prevotella sp. (oral clone BE073 phylotype)k 1 1 2
Unknown Capnocytophaga-like sp.l 1
Fusobacteria
Fusobacterium naviforme 1 3
Fusobacterium nucleatum subsp. nucleatum 1 2 1
Eukaryotes
Candida albicans 2 3 1
Saccharomyces sp. 1
a Multiple names are given wherever partial 16S sequences from isolates exhibited a significant (99%) match to more than one species. Where the sequence was
novel or homologous only to a phylotype from an unrecognized species, the accession numbers of the appropriate GenBank entries are given below.
b Novel Moraxella-like sp. isolate S12-08; accession no. AY880059.
c Unknown Bifidobacterium sp.; accession no. AY880048 and AY880049. Also homologous to oral strain H6-M4 phylotype (accession no. AF385524) and the
proposed species “Bifidobacterium urinalis,” which does not currently have standing in nomenclature (strains CCUG 26938 and CCUG 344441, accession no. AJ278694
and AJ278695, respectively).
d Scardovia-like sp. isolate; accession no. AY880045. Sequence match to Scardovia genomospecies C1 (accession no. AY278626).
e Novel Corynebacterium-like sp. isolate S18-03; accession no. AY880057.
f Novel Corynebacterium-like sp. isolate T13-01; accession no. AY880058.
g Novel Georgenia-like sp. isolate T04-04; accession no. AY880044.
h Novel Olsenella-like sp. isolates S13-10 and N13-17; accession no. AY880047 and AY880046.
i Unknown Streptococcus sp. isolates S16-08 and S16-11; accession no. AY880050 and AY880051. Sequence match to oral strain T4-E3 phylotype (accession no. AF385526).
j Novel bacterium isolate N14-24; accession no. AY880043.
k Unknown Prevotella sp. isolates N12-20, N19-22, N19-31, T05-04; accession no. AY880052 to AY880055, respectively. Sequence match to oral clone BE073 phylotype
(accession no. AF385551).
l Novel Capnocytophaga-like sp. isolate S12-14; accession no. AY880056.
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A number of isolates were detected which, although not
typically regarded as common members of the oral microflora,
have been isolated from the oral cavity previously and/or are
known to be human pathogens, for example, those belonging
to the genera Micrococcus, Propionibacterium, Streptomyces,
Bacillus, Enterococcus, Exiguobacterium, Staphylococcus, and
Pseudomonas.
As the successful surface decontamination indicates that the
bacteria isolated from the samples were not carried over from
other sources, such as saliva, it is interesting to note that so
many species, including ones not commonly regarded as patho-
genic, were present in the tumor tissue. This may support the
emerging findings that many different bacterial species are
capable of infecting oral tissue and invading epithelial cells.
For instance, it is of some interest to note that recent reports
find streptococci to be a major component of this epithelial
intracellular microflora (26), as several members of this genus
were isolated from within both tumorous and nontumorous
samples. The detection of Streptococcus anginosus in these
tissues is also particularly noteworthy because it supports the
findings from previous studies in which S. anginosus DNA was
detected in head and neck carcinoma by PCR (18, 28, 31).
Additionally, the presence of Streptococcus mitis/Streptococcus
oralis in both the nontumorous and tumorous samples is con-
sistent with the previously reported detection of these micro-
organisms in esophageal carcinoma and control tissues by mo-
lecular means (21).
The great diversity of species isolated together with the
relatively low number of patients and specimens used in this
study make it difficult to apply statistical analyses to draw
conclusions regarding bacterial specificity. However, a number
of interesting trends are apparent from the results. In all cases,
the superficial tissues yielded exactly the same isolates as the
corresponding deep-tissue specimens plus, in most cases, ad-
ditional species. This may indicate a degree of restriction of
bacteria in the deeper tumor tissue in comparison to the over-
lying mucosal sites. Perhaps not all species coming from the
oral cavity and invading the mucosa can invade or survive in
the tumorous tissue.
Several species detected in the nontumorous control tissue
were not detected in the tumor tissues, and vice versa. For
instance, Exiguobacterium oxidotolerans, Prevotella melanino-
genica, Staphylococcus aureus, Veillonella parvula, and species
of Bacteria and Micrococcus were isolated only from tumorous
specimens and not at all from nontumorous ones. Conversely,
Moraxella osloensis, Prevotella veroralis, and species of Actino-
myces were grown only from nontumorous tissues. This could
indicate that, while bacteria are present within all the oral
mucosal tissues, there are potentially significant differences
between the microfloras within tumorous compared to nontu-
morous mucosae. Although we were unable to apply full hy-
pothesis-testing statistics to support this finding, the observed
alteration in microflora composition may perhaps be similar to
the reported differences in the proportions of salivary bacteria
that can theoretically be used as a predictor for OSCC (17).
The simple descriptive parameters used in this study suggest six
candidate species, isolated from over 10% more of the amal-
gamated tumorous than nontumorous samples, that may prove
to be significantly associated with OSCC tissue (Table 2). Sim-
ilarly, there were 11 taxa that were in proportionally at least
10% more of the control samples than the tumorous tissues,
which may represent the species that are most likely not to be
associated with OSCC.
It is interesting to note that the majority of species isolated
were saccharolytic and acid tolerant. For instance, yeasts, ac-
tinomycetes, bifidobacteria, lactobacilli, streptococci, and veil-
lonellae, all of which were detected in this study, are known to
produce short-chain organic acids from carbohydrates and
consequently to lower the pH of their local environment (2, 30,
33). Asaccharolytic or weakly fermentative species isolated
from these specimens, such as Fusobacterium and Prevotella
species, have also been shown to be capable of survival at
relatively low pHs (34). The microenvironment of solid tumors
is typically hypoxic, with an acidic extracellular pH (24), and so
TABLE 2. The relative proportions of the different tissue sample types that were positive for certain species of bacteria
Species
Proportion of tissue samples positive for species (%)a
Deep tumor Superficial Tumorous Nontumorous control Difference
Micrococcus luteus 25.0 31.6 28.2 0.0 28.2
Prevotella melaninogenica 10.0 15.8 12.8 0.0 12.8
Exiguobacterium oxidotolerans 10.0 10.5 10.3 0.0 10.3
Fusobacterium naviforme 5.0 15.8 10.3 0.0 10.3
Staphylococcus aureus 10.0 10.5 10.3 0.0 10.3
Veillonella parvula 10.0 10.5 10.3 0.0 10.3
Prevotella sp. (oral clone BE073 phylotype) 5.0 5.3 5.1 16.7 11.5
Rothia mucilaginosa 5.0 5.3 5.1 16.7 11.5
Streptococcus salivarius 10.0 15.8 12.8 25.0 12.2
Actinomyces odontolyticus 0.0 5.3 2.6 16.7 14.1
Moraxella osloensis 0.0 0.0 0.0 16.7 16.7
Prevotella veroralis 0.0 0.0 0.0 16.7 16.7
Propionibacterium acnes 30.0 36.8 33.3 50.0 16.7
Atopobium parvulum 5.0 10.5 7.7 25.0 17.3
Streptococcus parasanguinis 15.0 31.6 23.1 41.7 18.6
Veillonella dispar 5.0 5.3 5.1 25.0 19.9
Streptococcus mitis/oralis 10.0 26.3 17.9 41.7 23.7
a “Tumorous” represents the combined proportions of both superficial and deep samples. The difference in detected proportions between tumorous and non-
tumorous control tissues is shown. Only the species for which there was at least a 10% difference in proportions are listed.
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it is not surprising that there might be a degree of selectivity in
favor of acid tolerance. To what degree the presence of acid-
producing bacteria within tumors contributes to the acidic mi-
croenvironment is as yet unknown.
Based on the 16S rRNA gene sequence data, several of the
cultivated isolates appear to represent species either not pre-
viously characterized or without standing in the current no-
menclature. There were 7 different phylotypes (from a total of
10 isolates) that failed to demonstrate significant homology
(	99% sequence match) to any GenBank entry. Given the
current wide-ranging nature of the sequence databases for
known bacteria, it is possible that these represent “novel”
species. Interestingly, an additional nine isolates showed sig-
nificant sequence matches to existing sequences representing
taxa that are unnamed and have seemingly not been cultured
or characterized before. Four specimens contained a Prevotella
species with a significant sequence match to “oral clone
BE073,” an uncultured putative species detected in purified
crevicular epithelial cells (11). One tumor tissue specimen
yielded an isolate matching “Scardovia genomospecies C1,” a
taxon recently detected in the microflora of dental caries (19).
A Streptococcus species was detected from one superficial spec-
imen that matched the “Streptococcus sp. oral strain T4-E3”
phylotype, previously detected by molecular means on the sur-
face of the tongue dorsa (11). Isolates were cultivated from two
superficial tissues that sequence-matched “Bifidobacterium sp.
oral strain H6-M4,” another taxon cloned from the tongue
dorsa microflora (11). The 16S sequence for these isolates also
matched the proposed species “Bifidobacterium urinalis,” al-
though this nomenclature is as yet unpublished and has no
current standing. It will be of great interest to characterize
these isolates further.
The implications of the presence of a diversity of viable
bacteria deep within the tissue of squamous cell carcinoma are
unclear. Although it has been shown in animal models that
bacteria injected intravenously may seed to tumor tissue (39),
the types of bacteria isolated and the fact that the composition
of the deep tissue microflora was similar to, but less species
rich than, the overlying mucosa tend to imply a local origin for
the bacteria detected within the tumor. The apparent differ-
ences between the microflora of the tumor and control tissues
suggest a degree of bacterial specificity that merits further
study. For instance, it would be useful in future studies to
include an assessment of microbial load to determine the nu-
merical predominance of selected species. As evidence that
bacteria are involved in the development of many different
cancers increases, it is interesting to speculate that the species
isolated from the tumor tissue may play a role in the carcino-
genic process, a concept worthy of further investigation.
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